Trademarks
REYXARGO
- Serial number
- 99871333
- Registration number
- Not registered
- Filed
- 2026-06-08
- Registered
- Not registered
- Status
- Pending application (USPTO status code 641, 2026-10-17; as of the dataset)
- Classes
- 005
- Elsewhere
- USPTO TSDR record (current status) ↗
- Source
- TRTDXFAP, file of 2026-10-18
Goods and services
Pharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, auto-immune diseases, solid organ transplant rejection, autoinflammatory disease, blood disease, multiple sclerosis, ulcerative colitis, cystic fibrosis, arthritis, Alzheimer’s disease, autism spectrum disorder and musculoskeletal and skin disease; Antivirals; Antibodies for medical purposes; Biological preparations for the treatment of cancer; Anticoagulants; Stem cells for medical purposes; Radiopharmaceutical preparations for the treatment of cancer and solid tumors; Diagnostic radiopharmaceutical preparations; Diagnostic preparations for medical purposes
Owners
| Owner | Role | Entity | Place | Also on furp.org | Source |
|---|---|---|---|---|---|
| Celgene Corporation | Original applicant | Corporation | Princeton, NJ | TRTDXFAP, file of 2026-10-18 |
Assignment history
No recorded assignments on file for this mark.
USPTO bulk data: the Trademark Case Files Dataset (TRCFECO2; the latest release, March 2024, runs through 2023) for marks, owners, classes and goods and services; the Trademark Assignment Dataset (TRASECO) for assignments. Marks filed in the last 20 years, plus older marks still registered. Status here is read from the dataset’s dates and status code; TSDR has the current status. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.